Skip navigation

“In my company, CME is now considered too risky. We're pulling back,” said a participant at the Pharmaceutical Alliance for CME breakout session at the American Medical Association's conference on CME Provider/Industry Collaboration, held in September in Baltimore.

Register to view the full article

Register for and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.